Diabetes Management Regulatory Compliance Diagnostic Tests Regulatory Approval Hearing Aids Prosthetics Implantable Devices Manufacturing Product Safety Ophthalmology Cardiovascular Devices Wearable Technology Sleep Apnea Devices Insulin Pumps Pulse Oximeters Cardiovascular Health Cardiology Pharmaceuticals Implants Cardiovascular Treatments Continuous Glucose Monitors Insulin Pump Continuous Glucose Monitoring Patient Safety FDA Regulations Health Monitoring Robotic Surgery Earnings Reports Wearable Devices Intraocular Lenses Heart Pumps Market Trends Breathing Machines Implantable Cardioverter-Defibrillator Blood Glucose Monitoring Diagnostics Regulatory Affairs AI-powered Medical Devices Cardiac Monitoring Market Demand Diabetes Care Ventilators Brain Implants Regulations Glucose Monitoring Infusion Pumps Pulse Oximetry Bioelectronic Medicine Tariffs Market Access Clinical Trials Surgical Systems Organ Transplantation Home Testing Patient Care Innovation Regulatory Agencies Public Procurement Safety Regulations Heart Pump Neuroprosthetics Implantable Technology MedTech Manufacturing Technologies Over-the-Counter Devices Surgical Devices Cardiac Devices Home Health Care Sleep Medicine Stryker Corp. Medtronic PLC Cooper Companies Earplugs Automated Systems Wearable Health Technology Magseed Sleep Apnea Market Regulation COVID-19 Testing Elective Procedures Sales Trends Preventive Care Smart Connected Care Solutions Vascular Procedures Hearing Solutions Implantable Materials End-of-Life Care Recalls Market Competition Safety Measures Cancer Screening Spinal Nerve Stimulation Patient Information FDA Reporting Heart Health Surgical Robotics Continuous Glucose Monitor Continuous Glucose Monitor (CGM) Pricing Health Apps
Plaintiff firms say investors were misled about safety risks tied to Baxter’s Novum infusion pumps.